Carmignac Gestion’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Carmignac Gestion’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-39,468	Closed	-$649K	–	166
2023 Q4	$649K	Buy	+39,468	New	+$621K	0.01%	134
2019 Q2	–	Sell	-3,249	Closed	-$581K	–	135
2019 Q1	$581K	Buy	+3,249	New	+$488K	0.01%	91

Carmignac Gestion's ORTX Position: Q1 2024 in Review

Carmignac Gestion sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 39,468 shares — an estimated $649K sold.

Carmignac Gestion first reported a position in ORTX in Q1 2019 and held it in 2 quarters. The position peaked at $649K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Carmignac Gestion reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Carmignac Gestion sold 39,468 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $649K.
Carmignac Gestion first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 2 quarters.
Carmignac Gestion's Orchard Therapeutics plc American Depositary Shares position peaked at $649K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Carmignac Gestion's 13F filing for Q1 2024, filed 14 May 2024.